2007
DOI: 10.1002/9780470151808.sc02a04s3
|View full text |Cite
|
Sign up to set email alerts
|

Isolation and Assessment of Long‐Term Reconstituting Hematopoietic Stem Cells from Adult Mouse Bone Marrow

Abstract: Suspensions of multipotent hematopoietic stem cells with long‐term repopulating activity can now be routinely isolated from adult mouse bone marrow at purities of 30%. A robust method for obtaining these cells in a single step using multiparameter cell sorting to isolate the CD45midlin−Rho−SP subset is described here, together with a detailed protocol for assessing their regenerative activity in mice transplanted with single cells. These procedures provide unprecedented power and precision for characterizing t… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
13
0

Year Published

2009
2009
2024
2024

Publication Types

Select...
6
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 20 publications
(13 citation statements)
references
References 59 publications
0
13
0
Order By: Relevance
“…For all transplantation assays, recipients were C57BL/6J (CD45.1) mice irradiated with a split dose (2×475 cGy) and all transplants were performed by standard intravenous tail vein injection using a 29.5G insulin syringe. Peripheral blood was collected and analyzed as described previously [64].…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…For all transplantation assays, recipients were C57BL/6J (CD45.1) mice irradiated with a split dose (2×475 cGy) and all transplants were performed by standard intravenous tail vein injection using a 29.5G insulin syringe. Peripheral blood was collected and analyzed as described previously [64].…”
Section: Methodsmentioning
confidence: 99%
“…For all transplantation assays, peripheral blood samples were collected from the tail vein of mice at 4, 8, and 16 wk after transplantation and analyzed for repopulation levels as described previously [64]. Antibodies used were CD45.1-PE (Clone A20, Biolegend), CD45.2-FITC (Clone 104, BD), Ly6g-Pacific Blue (Clone RB6-8C5, Biolegend), Mac1-APC (Clone M1/70, Biolegend), B220-APC (Clone RA3-6B2 eBiosciences, San Diego, CA), and CD3e-Pacific Blue (Clone 500A2, BD).…”
Section: Methodsmentioning
confidence: 99%
“…All experiments used C57BL/6J (B6)-Ly5.1 or -Ly5.2 mice as donors and congenic sublethally irradiated B6-W 41 /W 41 -Ly5.1 and -Ly5.2 (W 41 -5.1 and W 41 -5.2) mice as recipients according to institutionally approved procedures. Transplantations and analyses of transplanted mice were performed as previously described (Kent et al, 2007). The HSC subtype origin of each clone was first determined 16 weeks posttransplant and for secondary transplants was reconfirmed within 1 week of the secondary transplantation.…”
Section: Experimental Procedures Micementioning
confidence: 99%
“…23 Peripheral blood samples were collected from the tail vein of some mice at 4 weeks and all mice at 8, 16, and 24 weeks after transplantation and RBCs lysed using NH 4 Cl. All samples were stained with both anti-CD45.1-APC (eBiosciences, San Diego, CA) and anti-CD45.2-FITC (Terry Fox Laboratory) to enable donor and recipient WBCs to be distinguished and to ensure that any double positive CD45.1 and CD45.2 events were excluded from the analysis of donor contributions to specific WBC subsets.…”
Section: Transplantation Of Cells and Analysis Of Mice That Received mentioning
confidence: 99%